Oncogenesis
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.0 | Q1 | 81.1% | 2.081 | Q1 | 95.6% |
| 2024 | 6.4 | Q1 | 85.0% | 2.185 | Q1 | 96.0% |
| 2023 | 5.9 | Q1 | 80.6% | 1.855 | Q1 | 95.0% |
| 2022 | 6.2 | Q1 | 80.3% | 1.610 | Q1 | 93.8% |
| 2021 | 6.5 | Q2 | 78.2% | 1.763 | Q1 | 94.9% |
| 2020 | — | — | 2.497 | Q1 | 96.9% | |
| 2019 | — | — | 2.118 | Q1 | 96.1% | |
| 2018 | — | — | 1.995 | Q1 | 95.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2157-9024
region
Western Europe
coverage
2012-2026